A Phase I, the Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002

Clinical trial NCT06162299 · TERMINATED

Trial details

NCT number: NCT06162299
Sponsor: Yisheng Biopharma (Singapore) Pte. Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2024-07-01
Primary completion: 2024-09-30
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.